138 related articles for article (PubMed ID: 21518780)
21. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
[TBL] [Abstract][Full Text] [Related]
22. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
[TBL] [Abstract][Full Text] [Related]
23. Rituximab maintenance therapy for follicular lymphoma: no better than watchful waiting.
Prescrire Int; 2012 Mar; 21(125):62. PubMed ID: 22428182
[TBL] [Abstract][Full Text] [Related]
24. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
Czuczman MS; Koryzna A; Mohr A; Stewart C; Donohue K; Blumenson L; Bernstein ZP; McCarthy P; Alam A; Hernandez-Ilizaliturri F; Skipper M; Brown K; Chanan-Khan A; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-Lopez A; Bernstein SH
J Clin Oncol; 2005 Feb; 23(4):694-704. PubMed ID: 15681517
[TBL] [Abstract][Full Text] [Related]
25. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Zinzani PL; Pulsoni A; Perrotti A; Soverini S; Zaja F; De Renzo A; Storti S; Lauta VM; Guardigni L; Gentilini P; Tucci A; Molinari AL; Gobbi M; Falini B; Fattori PP; Ciccone F; Alinari L; Martelli M; Pileri S; Tura S; Baccarani M
J Clin Oncol; 2004 Jul; 22(13):2654-61. PubMed ID: 15159414
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE
J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637
[TBL] [Abstract][Full Text] [Related]
27. Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.
Solal-Céligny P; Bellei M; Marcheselli L; Pesce EA; Pileri S; McLaughlin P; Luminari S; Pro B; Montoto S; Ferreri AJ; Deconinck E; Milpied N; Gordon LI; Federico M
J Clin Oncol; 2012 Nov; 30(31):3848-53. PubMed ID: 23008294
[TBL] [Abstract][Full Text] [Related]
28. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
29. Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma.
Abulayha AM; Tabal SA; Shawesh EI; Elbasir MA; Elbanani AS; Lamami YM; Bredan A
Leuk Res; 2010 Mar; 34(3):307-11. PubMed ID: 19580998
[TBL] [Abstract][Full Text] [Related]
30. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
Behl D; Ristow K; Markovic SN; Witzig TE; Habermann TM; Colgan JP; Inwards DJ; White WL; Ansell SM; Micallef IN; Johnston PB; Porrata LF
Br J Haematol; 2007 Jun; 137(5):409-15. PubMed ID: 17433025
[TBL] [Abstract][Full Text] [Related]
31. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
32. Rituximab maintenance therapy of relapsed or refractory follicular lymphoma, with longer follow-up: no proven impact on survival.
Prescrire Int; 2012 Mar; 21(125):63. PubMed ID: 22428183
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
34. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
Budau L; Wilhelm C; Moll R; Jäkel J; Hirt C; Dölken G; Maschmeyer G; Neubauer E; Strauch K; Burchert A; Herold M; Neubauer A
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2149-2156. PubMed ID: 31273513
[TBL] [Abstract][Full Text] [Related]
35. Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.
Junlén HR; Lockmer S; Kimby E; Wahlin BE
Ann Hematol; 2020 Oct; 99(10):2357-2366. PubMed ID: 32808106
[TBL] [Abstract][Full Text] [Related]
36. Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy.
Wahlin BE; Sundström C; Sander B; Christensson B; Jeppsson-Ahlberg Å; Hjalmarsson E; Holte H; Østenstad B; Brown PD; Smeland EB; Kimby E
Leuk Lymphoma; 2014 Feb; 55(2):288-95. PubMed ID: 23662992
[TBL] [Abstract][Full Text] [Related]
37. T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome.
Magnano L; Martínez A; Carreras J; Martínez-Trillos A; Giné E; Rovira J; Dlouhy I; Baumann T; Balagué O; Campo E; López-Guillermo A; Villamor N
Leuk Lymphoma; 2017 Apr; 58(4):842-850. PubMed ID: 27687692
[TBL] [Abstract][Full Text] [Related]
38. Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients.
Xerri L; Huet S; Venstrom JM; Szafer-Glusman E; Fabiani B; Canioni D; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Laurent C; Gelas-Dore B; Bolen CR; Punnoose E; Bouabdallah R; Brice P; Morschhauser F; Cartron G; Olive D; Salles G;
Hum Pathol; 2017 Jun; 64():128-136. PubMed ID: 28414090
[TBL] [Abstract][Full Text] [Related]
39. Rapid-onset, prolonged bone marrow failure following rituximab therapy of follicular lymphoma.
Debatin L; Schmitt-Graeff A; Veelken H
Onkologie; 2011; 34(6):322-4. PubMed ID: 21625186
[No Abstract] [Full Text] [Related]
40. Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma.
Sarkozy C; Seymour JF; Ferme C; Caballero D; Ghesquieres H; Leppa S; Delarue R; Pedersen LM; Mounier C; Gomes Da Silva M; Chassagne-Clement C; Maerevoet M; Salles G
Blood; 2014 Apr; 123(17):2740-2. PubMed ID: 24764560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
